Chapter 2 Organized Trafficking of Anandamide and Related Lipids

Vitamins and Hormones

Volumn 81, Issue C, 2009, Pages 25-53

  Yates, Marla L ^a   Barker, Eric L ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; ANANDAMIDE; ARACHIDONIC ACID DERIVATIVE; CARRIER PROTEIN; ENDOCANNABINOID; FATTY ACID TRANSPORTER;

ANIMAL; BIOSYNTHESIS; CELL MEMBRANE; HUMAN; LIPID METABOLISM; METABOLISM; REVIEW; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ARACHIDONIC ACIDS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; ENDOCANNABINOIDS; FATTY ACID TRANSPORT PROTEINS; HUMANS; LIPID METABOLISM; MEMBRANE MICRODOMAINS; POLYUNSATURATED ALKAMIDES; SIGNAL TRANSDUCTION;

EID: 67651161908     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(09)81002-9     Document Type: Review

References (155)

1. Abumrad N.A., el Maghrabi M.R., Amri E.Z., Lopez E., and Grimaldi P.A. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J. Biol. Chem. 268 (1993) 17665-17668
2. Abumrad N., Harmon C., and Ibrahimi A. Membrane transport of long-chain fatty acids: Evidence for a facilitated process. J. Lipid Res. 39 (1998) 2309-2318
3. Abumrad N., Coburn C., and Ibrahimi A. Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1441 (1999) 4-13
4. Alexander J.P., and Cravatt B.F. The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine Hydrolases. J. Am. Chem. Soc. 128 (2006) 9699-9704
5. Alpy F., and Tomasetto C. Give Lipids a START: The StAR-related lipid transfer (START) domain in mammals. J. Cell Sci. 118 (2005) 2791-2801
6. Arakane F., Sugawara T., Nishino H., Liu Z., Holt J., Pain D., Stocco D., Miller W., and Strauss J. Steroidogenic acute regulatory protein (StAR) retains activity in the absence of its mitochondrial import sequence: Implications for the mechanism of StAR action. Proc. Natl. Acad. Sci. USA 93 (1996) 13731-13736
7. Ashton J.C. Cannabinoids for the treatment of inflammation. Curr. Opin. Invest. Drugs 8 (2007) 373-384
8. Ashton J.C., and Smith P.F. Cannabinoids and cardiovascular disease: The outlook for clinical treatments. Curr. Vasc. Pharmacol. 5 (2007) 175-185
9. Balas L., Hellal M., Rossi J.C., and Durand T. Synthesis of a photoactivatable probe of the anandamide re-uptake. Nat. Prod. Res. 19 (2005) 419-423
10. Bari M., Paradisi A., Pasquariello N., and Maccarrone M. Cholesterol-dependent modulation of type 1 cannabinoid receptors in nerve cells. J. Neurosci. Res. 81 (2005) 275-283
11. Bari M., Battista N., Fezza F., Finazzi-Agro A., and Maccarrone M. Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells: Implications for anandamide-induced apoptosis. J. Biol. Chem. 280 (2005) 12212-12220
12. Bari M., Spagnuolo P., Fezza F., Oddi S., Pasquariello N., Finazzi-Agro A., and Maccarrone M. Effect of lipid rafts on CB2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells. J. Immunol. 177 (2006) 4971-4980
13. Battista N., Fezza F., Finazzi-Agro A., and Maccarrone M. The endocannabinoid system in neurodegeneration. Ital. J. Biochem. 55 (2006) 283-289
14. Berk P.D., Wada H., Horio Y., Potter B.J., Sorrentino D., Zhou S., Isola L.M., Stump D., Kiang C., and Thung S. Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related. Proc. Natl. Acad. Sci. USA 87 (1990) 3484-3488
15. Berk P.D., Zhou S.L., Kiang C.L., Stump D., Bradbury M., and Isola L.M. Uptake of long chain free fatty acids is selectively up-regulated in adipocytes of zucker rats with genetic obesity and non-insulin-dependent diabetes mellitus. J. Biol. Chem. 272 (1997) 8830-8835
16. Bojesen I.N., and Hansen H.S. Binding of anandamide to bovine serum albumin. J. Lipid Res. 44 (2003) 1790-1794
17. Bonen A., Parolin M.L., Steinberg G.R., Calles-Escandon J., Tandon N.N., Glatz J.F.C., Luiken J.J.F.P., Heigenhauser G., and Dyck D.J. Triacylglycerol Accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J. 18 (2004) 1144-1146
18. Bonen A., Chabowski A., Luiken J.J.F.P., and Glatz J.F.C. Mechanisms and regulation of protein-mediated cellular fatty acid uptake: Molecular, biochemical, and physiological evidence. Physiology 22 (2007) 15-28
19. Bouaboula M., Hilairet S., Marchand J., Fajas L., Fur G.L., and Casellas P. Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation. Eur. J. Pharmacol. 517 (2005) 174-181
20. Brown D.A., and London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275 (2000) 17221-17224
21. Cadas H., di Tomaso E., and Piomelli D. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci. 17 (1997) 1226-1242
22. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., and Julius D. The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 389 (1997) 816-824
23. Caulfield M.P., and Brown D.A. Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br. J. Pharmacol. 106 (1992) 231-232
24. Chabowski A., Gorski J., Luiken J.J.F.P., Glatz J.F.C., and Bonen A. Evidence for concerted action of FAT/CD36 and FABPpm to increase fatty acid transport across the plasma membrane. Prostaglandins Leukot. Essent. Fatty Acids 77 (2007) 345-353
25. Coe N.R., Smith A.J., Frohnert B.I., Watkins P.A., and Bernlohr D.A. The fatty acid transport protein (FATP1) is a very long chain Acyl-CoA synthetase. J. Biol. Chem. 274 (1999) 36300-36304
26. Coort S., Bonen A., van der Vusse G., Glatz J., and Luiken J. Cardiac substrate uptake and metabolism in obesity and type-2 diabetes: Role of sarcolemmal substrate transporters. Mol. Cell. Biochem. 299 (2007) 5-18
27. Cravatt B.F., Giang D.K., Mayfield S.P., Boger D.L., Lerner R.A., and Gilula N.B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384 (1996) 83-87
28. Dainese E., Oddi S., Bari M., and Maccarrone M. Modulation of the endocannabinoid system by lipid rafts. Curr. Med. Chem. 14 (2007) 2702-2715
29. Day T.A., Rakhshan F., Deutsch D.G., and Barker E.L. Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide. Mol. Pharmacol. 59 (2001) 1369-1375
30. De Petrocellis L., Bisogno T., Maccarrone M., Davis J.B., Finazzi-Agro A., and Di Marzo V. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem. 276 (2001) 12856-12863
31. Deutsch D.G., Glaser S.T., Howell J.M., Kunz J.S., Puffenbarger R.A., Hillard C.J., and Anbumrad N. The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase. J. Biol. Chem. 276 (2001) 6967-6973
32. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
33. Dickason-Chesterfield A., Kidd S., Moore S., Schaus J., Liu B., Nomikos G., and Felder C. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors. Cell. Mol. Neurobiol. 26 (2006) 1-17
34. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.C., and Piomelli D. Formation and inactivation of endogenous cannabinoid anandanide in central neurons. Nature 372 (1994) 686-691
35. DiRusso C.C., Li H., Darwis D., Watkins P.A., Berger J., and Black P.N. Comparative biochemical studies of the murine fatty acid transport proteins (FATP) expressed in yeast. J. Biol. Chem. 280 (2005) 16829-16837
36. DiRusso C.C., Darwis D., Obermeyer T., and Black P.N. Functional domains of the fatty acid transport proteins: Studies using protein chimeras. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1781 (2008) 135-143
37. Doege H., and Stahl A. Protein-mediated fatty acid uptake: Novel insights from in vivo models. Physiology 21 (2006) 259-268
38. Ehehalt R., Fullekrug J., Pohl J., Ring A., Herrmann T., and Stremmel W. Translocation of long chain fatty acids across the plasma membrane-Lipid rafts and fatty acid transport proteins. Mol. Cell. Biochem. 284 (2006) 135-140
39. Eyre N.S., Cleland L.G., Tandon N.N., and Mayrhofer G. Importance of the carboxyl terminus of FAT/CD36 for plasma membrane localization and function in long-chain fatty acid uptake. J. Lipid Res. 48 (2007) 528-542
40. Fasia L., Karava V., and Siafaka-Kapadai A. Uptake and metabolism of [3H]anandamide by rabbit platelets-Lack of transporter?. Eur. J. Biochem. 270 (2003) 3498-3506
41. Febbraio M., Hajjar D.P., and Silverstein R.L. CD36: A class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108 (2001) 785-791
42. Febbraio M., Guy E., Coburn C., Knapp F.F., Beets A.L., Abumrad N.A., and Silverstein R.L. The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36. Mol. Cell. Biochem. 239 (2002) 193-197
43. Fegley D., Kathuria S., Mercier R., Li C., Goutopoulos A., Makriyannis A., and Piomelli D. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proc. Natl. Acad. Sci. USA 101 (2004) 8756-8761
44. Felder C.C., Briley E.M., Axelrod J., Simpson J.T., Mackie K., and Devane W.A. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. USA 90 (1993) 7656-7660
45. Feng L., Chan W.W., Roderick S.L., and Cohen D.E. High-level expression and mutagenesis of recombinant human phosphatidylcholine transfer protein using a synthetic gene: Evidence for a C-terminal membrane binding domain. Biochemistry 39 (2000) 15399-15409
46. Fezza F., Oddi S., Di Tommaso M., De Simone C., Rapino C., Pasquariello N., Dainese E., Finazzi-Agro A., and Maccarrone M. Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation. J. Lipid Res. 49 (2008) 1216-1223
47. Fowler C.J., Tiger G., Ligresti A., Lopez-Rodriguez M.L., and Di Marzo V. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis-A difficult issue to handle. Eur. J. Pharmacol. 492 (2004) 1-11
48. Freund T.F., Katona I., and Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83 (2003) 1017-1066
49. Gaoni Y., and Mechoulam R. The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish. J. Am. Chem. Soc. 93 (1971) 217-224
50. Gerdeman G.L., Ronesi J., and Lovinger D.M. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 5 (2002) 446-451
51. Giang D.K., and Cravatt B.F. Molecular characterization of human and mouse fatty acid amide hydrolases. Proc. Natl. Acad. Sci. USA 94 (1997) 2238-2242
52. Glaser S.T., Abumrad N.A., Fatade F., Kaczocha M., Studholme K.M., and Deutsch D.G. Evidence against the presence of an anandamide transporter. Proc. Natl. Acad. Sci. USA 100 (2003) 4269-4274
53. Glaser S.T., Deutsch D.G., Studholme K.M., Zimov S., and Yazulla S. Endocannabinoids in the intact retina: [3H]Anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide. Visual Neurosci. 22 (2005) 693-705
54. Glaser S.T., Kaczocha M., and Deutsch D.G. Anandamide transport: A critical review. Life Sci. 77 (2005) 1584-1604
55. Guindon J., and Hohmann A.G. Cannabinoid CB2 receptors: A therapeutic target for the treatment of inflammatory and neuropathic pain. Br. J. Pharmacol. 153 (2007) 319-334
56. Hamilton J.A. New insights into the roles of proteins and lipids in membrane transport of fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 77 (2007) 355-361
57. Hanus L., Abu-Lafi S., Fride E., Breuer A., Vogel Z., Shalev D.E., Kustanovich I., and Mechoulam R. 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc. Natl. Acad. Sci. USA 98 (2001) 3662-3665
58. Heather L.C., Cole M.A., Lygate C.A., Evans R.D., Stuckey D.J., Murray A.J., Neubauer S., and Clarke K. Fatty acid transporter levels and palmitate oxidation rate correlate with ejection fraction in the infarcted rat heart. Cardiovasc. Res. 72 (2006) 430-437
59. Hillard C.J., and Jarrahian A. The movement of n-arachidonoylethanolamine (anandamide) across cellular membranes. Chem. Phys. Lipids 108 (2000) 123-134
60. Hillard C.J., and Jarrahian A. Cellular accumulation of anandamide: Consensus and controversy. Br. J. Pharmacol. 140 (2003) 802-808
61. Hillard C.J., Edgemond W.S., Jarrahian A., and Campbell W.B. Accumulation of n-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J. Neurochem. 69 (1997) 631-638
62. Hillard C.J., Shi L., Tuniki V.R., Falck J.R., and Campbell W.B. Studies of anandamide accumulation inhibitors in cerebellar granule neurons: Comparison to inhibition of fatty acid amide hydrolase. J. Mol. Neurosci. 33 (2007) 18-24
63. Hohmann A.G., and Suplita R.L. Endocannabinoid mechanisms of pain modulation. AAPS J. 8 (2006) E693-E708
64. Holloway G.P., Lally J., Nickerson J.G., Alkhateeb H., Snook L.A., Heigenhauser G.J.F., Calles-Escandon J., Glatz J.F.C., Luiken J.J.F.P., Spriet L.L., and Bonen A. Fatty acid binding protein facilitates sarcolemmal fatty acid transport but not mitochondrial oxidation in rat and human skeletal muscle. J. Physiol. (Oxford, UK) 582 (2007) 393-405
65. Holloway G.P., Luiken J.J.F.P., Glatz J.F.C., Spriet L.L., and Bonen A. Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: An overview. Acta Physiol. 194 (2008) 293-309
66. Howlett A.C. Cannabinoid receptor signaling. In: Pertwee R.G. (Ed). Cannabinoids (2005), Springer, Berlin-Heidelberg 53-79
67. Huffman J.W., and Marriott K.S.C. Recent advances in the development of selective ligands for the cannabinoid CB2 receptor. Curr. Top Med. Chem. (Sharjah, United Arab Emirates) 8 (2008) 187-204
68. Hui T.Y., and Bernlohr D.A. Fatty acid transporters in animal cells. Front. Biosci. 2 (1997) 222-231
69. Isola L.M., Zhou S., Kiang C., Stump D.D., Bradbury M.W., and Berk P.D. 3T3 Fibroblasts transfected with a cDNA for mitochondrial aspartate aminotransferase express plasma membrane fatty acid-binding protein and saturable fatty acid uptake. Proc. Natl. Acad. Sci. USA 92 (1995) 9866-9870
70. Iyer L.M., Koonin E.V., and Aravind L. Adaptations of the helix-grip fold for ligand binding and catalysis in the START domain superfamily. Proteins 43 (2001) 134-144
71. Jarrahian A., Watts V.J., and Barker E.L. D2 dopamine receptors modulate Gα-subunit coupling of the CB1 cannabinoid receptor. J. Pharmacol. Exp. Ther. 308 (2004) 880-886
72. Jia Z., Pei Z., Maiguel D., Toomer C., and Watkins P. The fatty acid transport protein (FATP) family: Very long chain acyl-CoA synthetases or solute carriers?. J. Mol. Neurosci. 33 (2007) 25-31
73. 2+-independent phosphatidylethanolamine n-acyltransferase generating the anandamide precursor and its congeners. J. Biol. Chem. 282 (2007) 3614-3623
74. Kaczocha M., Hermann A., Glaser S.T., Bojesen I.N., and Deutsch D.G. Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase. J. Biol. Chem. 281 (2006) 9066-9075
75. Kampf J.P., and Kleinfeld A.M. Is membrane transport of FFA mediated by lipid, protein, or both?. Physiology 22 (2007) 7-14
76. Karlsson M., Pahlsson C., and Fowler C.J. Reversible, temperature-dependent, and AM404-inhibitable adsorption of anandamide to cell culture wells as a confounding factor in release experiments. Eur. J. Pharm. Sci. 22 (2004) 181-189
77. Kirkham T.C., and Tucci S.A. Endocannabinoids in appetite control and the treatment of obesity. CNS Neurol. Disord. Drug Targets 5 (2006) 272-292
78. Klein T.W., Lane B., Newton C.A., and Friedman H. The cannabinoid system and cytokine network. Exp. Biol. Med. 225 (2000) 1-8
79. Q/11 G proteins. Proc. Natl. Acad. Sci. USA 102 (2005) 19144-19149
80. Leung D., Saghatelian A., Simon G.M., and Cravatt B.F. Inactivation of n-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry 45 (2006) 4720-4726
81. Lewis S.E., Listenberger L.L., Ory D.S., and Schaffer J.E. Membrane topology of the murine fatty acid transport protein 1. J. Biol. Chem. 276 (2001) 37042-37050
82. Ligresti A., Morera E., Van Der Stelt M., Monory K., Lutz B., Ortar G., and Di Marzo V. Further evidence for the existence of a specific process for the membrane transport of anandamide. Biochem. J. 380 (2004) 265-272
83. Liu J., Wang L., Harvey-White J., Osei-Hyiaman D., Razdan R., Gong Q., Chan A.C., Zhou Z., Huang B.X., Kim H.Y., and Kunos G. A biosynthetic pathway for anandamide. Proc. Natl. Acad. Sci. USA 103 (2006) 13345-13350
84. Lovinger D. Presynaptic modulation by endocannabinoids. In: Sudholf T.C., and Starke K. (Eds). Pharmacology of Neurotransmitter Release (2008), Springer, Berlin 435-477
85. Maccarrone M. CB2 receptors in reproduction. Br. J. Pharmacol. 153 (2007) 189-198
86. Maccarrone M., Bari M., Lorenzon T., Bisogno T., Di Marzo V., and Finazzi-Agro A. Anandamide uptake by human endothelial cells and its regulation by nitric oxide. J. Biol. Chem. 275 (2000) 13484-13492
87. Maccarrone M., Bari M., Battista N., and Finazzi-Agro A. Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation. Blood 100 (2002) 4040-4048
88. Mackie K., and Hille B. Cannabinoids inhibit n-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA 89 (1992) 3825-3829
89. Mackie K., and Stella N. Cannabinoid receptors and endocannabinoids: Evidence for new players. AAPS J. 8 (2006) E298-E306
90. Malfitano A.M., Toruner G.A., Gazzerro P., Laezza C., Husain S., Eletto D., Orlando P., De Petrocellis L., Terskiy A., Schwalb M., Vitale E., and Bifulco M. Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells. Immunol. Lett. 109 (2007) 145-154
91. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., and Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346 (1990) 561-564
92. McFarland M.J., and Barker E.L. Anandamide transport. Pharmacol. Ther. 104 (2004) 117-135
93. McFarland M.J., Porter A.C., Rakhshan F.R., Rawat D.S., Gibbs R.A., and Barker E.L. A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide. J. Biol. Chem. 279 (2004) 41991-41997
94. McFarland M.J., Terebova E.A., and Barker E.L. Detergent-resistant membrane microdomains in the disposition of the lipid signaling molecule anandamide. AAPS J. 8 (2006) E95-E100
95. McFarland M.J., Bardell T.K., Yates M.L., Placzek E.A., and Barker E.L. RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells. Mol. Pharmacol. 74 (2008) 101-108
96. McKinney M.K., and Cravatt B.F. Structure and function of fatty acide amide hydrolase. Annu. Rev. Biochem. 74 (2005) 411-432
97. Mechoulam R., Ben Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., Pertwee R.G., Griffin G., et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50 (1995) 83-90
98. Miller W.L. StAR search-What we know about how the Steroidogenic acute regulatory protein mediates mitochondrial cholesterol import. Mol. Endocrinol. 21 (2007) 589-601
99. Moore S.A., Nomikos G.G., Dickason-Chesterfield A.K., Schober D.A., Schaus J.M., Ying B.P., Xu Y.C., Phebus L., Simmons R.M.A., Li D., Iyengar S., and Felder C.C. Identification of a high-affinity binding site involved in the transport of endocannabinoids. Proc. Natl. Acad. Sci. USA 102 (2005) 17852-17857
100. Moriello A.S., Balas L., Ligresti A., Cascio M.G., Durand T., Morera E., Ortar G., and Di Marzo V. Development of the first potential covalent inhibitors of anandamide cellular uptake. J. Med. Chem. 49 (2006) 2320-2332
101. Mu J., Zhuang S.Y., Kirby M.T., Hampson R.E., and Deadwyler S.A. Cannabinoid receptors differentially modulate potassium A and D currents in hippocampal neurons in culture. J. Pharmacol. Exp. Ther. 291 (1999) 893-902
102. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
103. Muthian S., Nithipatikom K., Campbell W.B., and Hillard C.J. Synthesis and Characterization of a fluorescent substrate for the n-arachidonoylethanolamine (anandamide) transmembrane carrier. J. Pharmacol. Exp.Ther. 293 (2000) 289-295
104. Okamoto Y., Morishita J., Tsuboi K., Tonai T., and Ueda N. Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 279 (2004) 5298-5305
105. Okamoto Y., Wang J., Morishita J., and Ueda N. Biosynthetic pathways of the endocannabinoid anandamide. Chem. Biodiversity 4 (2007) 1842-1857
106. Ortega-Gutierrez S., Hawkins E.G., Viso A., Lopez-Rodriguez M.L., and Cravatt B.F. Comparison of anandamide transport in FAAH wild-type and knockout neurons: Evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake. Biochemistry 43 (2004) 8184-8190
107. O'sullivan S.E. Cannabinoids go nuclear: Evidence for activation of peroxisome proliferator-activated receptors. Br. J. Pharmacol. 152 (2007) 576-582
108. Pei Z., Fraisl P., Berger J., Jia Z., Forss-Petter S., and Watkins P.A. Mouse very long-chain acyl-CoA synthetase 3/fatty acid transport protein 3 catalyzes fatty acid activation but not fatty acid transport in MA-10 Cells. J. Biol. Chem. 279 (2004) 54454-54462
109. Pertwee R.G. Cannabinoids and multiple sclerosis. Pharmacol. Ther. 95 (2002) 165-174
110. Pike L.J., Han X., Chung K.N., and Gross R.W. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: A quantitative electrospray ionization/mass spectrometric analysis. Biochemistry 41 (2002) 2075-2088
111. Placzek E.A., Okamoto Y., Ueda N., and Barker E.L. Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown. Neuropharmacology 55 (2008) 1095-1104
112. Pohl J., Ring A., and Stremmel W. Uptake of long-chain fatty acids in HepG2 cells involves caveolae: Analysis of a novel pathway. J. Lipid Res. 43 (2002) 1390-1399
113. Pohl J., Ring A., Ehehalt R., Herrmann T., and Stremmel W. New concepts of cellular fatty acid uptake: Role of fatty acid transport proteins and of caveolae. Proc. Nutr. Soc. 63 (2004) 259-262
114. Ponting C.P., and Aravind L. START: A lipid-binding domain in StAR, HD-ZIP and signaling proteins. Trends Biochem. Sci. 24 (1999) 130-132
115. Porter A.C., Sauer J.M., Knierman M.D., Becker G.W., Berna M.J., Bao J., Nomikos G.G., Carter P., Bymaster F.P., Leese A.B., and Felder C.C. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J. Pharmacol. Exp. Ther. 301 (2002) 1020-1024
116. Rac M.E., Safranow K., and Poncyljusz W. Molecular basis of human CD36 gene mutations. Mol. Med. 13 (2007) 288-296
117. Rakhshan F., Day T.A., Blakely R.D., and Barker E.L. Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. J. Pharmacol. Exp. Ther. 292 (2000) 960-967
118. Ralevic V., Kendall D.A., Jerman J.C., Middlemiss D.N., and Smart D. Cannabinoid activation of recombinant and endogenous vanilloid receptors. Eur. J. Pharmacol. 424 (2001) 211-219
119. Ralevic V., Kendall D.A., Randall M.D., and Smart D. Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: Roles in regulation of cardiovascular function. Life Sci. 71 (2002) 2577-2594
120. Reggio P.H., and Traore H. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase. Chem. Phys. Lipids 108 (2000) 15-35
121. Rimmerman N., Hughes H.V., Bradshaw H.B., Pazos M.X., Mackie K., Prieto A.L., and Walker J.M. Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line. Br. J. Pharmacol. 153 (2007) 380-389
122. Ring A., Pohl J., Volkl A., and Stremmel W. Evidence for vesicles that mediate long-chain fatty acid uptake by human microvascular endothelial cells. J. Lipid Res. 43 (2002) 2095-2104
123. Rodriguez de Fonseca F., Del Arco I., Bermudez-Silva F.J., Bilbao A., Cippitelli A., and Navarro M. The endocannabinoid system: Physiology and pharmacology. Alcohol Alcohol 40 (2005) 2-14
124. Ross R.A. Anandamide and vanilloid TRPV1 receptors. Br. J. Pharmacol. 140 (2003) 790-801
125. Sandberg A., and Fowler C.J. Measurement of saturable and non-saturable components of anandamide uptake into P19 embryonic carcinoma cells in the presence of fatty acid-free bovine serum albumin. Chem. Phys. Lipids 134 (2005) 131-139
126. Schaap F.G., Hamers L., Van der Vusse G.J., and Glatz J.F.C. Molecular cloning of fatty acid-transport protein cDNA from rat. Biochim. Biophys. Acta (BBA) Gene Struct. Expr. 1354 (1997) 29-34
127. Schwenk R.W., Luiken J.J.F.P., Bonen A., and Glatz J.F.C. Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease. Cardiovasc. Res. 79 (2008) 249-258
128. Sfeir Z., Ibrahimi A., Amri E., Grimaldi P., and Abumrad N. Regulation of FAT/CD36 gene expression: Further evidence in support of a role of the protein in fatty acid binding/transport. Prostaglandins Leukot. Essent. Fatty Acids 57 (1997) 17-21
129. Simon G.M., and Cravatt B.F. Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-n-acyl ethanolamine precursors in mouse brain. J. Biol. Chem. 283 (2008) 9341-9349
130. Smart D., Gunthorpe M.J., Jerman J.C., Nasir S., Gray J., Muir A.I., Chambers J.K., Randall A.D., and Davis J.B. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (HVR1). Br. J. Pharmacol. 129 (2000) 227-230
131. Soccio R.E., and Breslow J.L. StAR-related lipid transfer (START) proteins: Mediators of intracellular lipid metabolism. J. Biol. Chem. 278 (2003) 22183-22186
132. Stahl A. A current review of fatty acid transport proteins (SLC27). Pflugers Arch. 447 (2004) 722-727
133. Stahl A., Gimeno R.E., Tartaglia L.A., and Lodish H.F. Fatty acid transport proteins: A current view of a growing family. Trends Endocrinol. Metab. 12 (2001) 266-273
134. Starowicz K., Nigam S., and Di Marzo V. Biochemistry and pharmacology of endovanilloids. Pharmacol. Ther. 114 (2007) 13-33
135. Stremmel W., Strohmeyer G., Borchard F., Kochwa S., and Berk P.D. Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc. Natl. Acad. Sci. USA 82 (1985) 4-8
136. Stuhlsatz-Krouper S.M., Bennett N.E., and Schaffer J.E. Substitution of alanine for serine 250 in the murine fatty acid transport protein inhibits long chain fatty acid transport. J. Biol. Chem. 273 (1998) 28642-28650
137. Stuhlsatz-Krouper S.M., Bennett N.E., and Schaffer J.E. Molecular aspects of fatty acid transport: Mutations in the IYTSGTTGXPK motif impair fatty acid transport protein function. Prostaglandins Leukot. Essent. Fatty Acids 60 (1999) 285-289
138. Stump D.D., Zhou S.L., and Berk P.D. Comparison of plasma membrane FABP and mitochondrial isoform of aspartate aminotransferase from rat liver. Am. J. Physiol. Gastrointest. Liver Physiol. 265 (1993) G894-G902
139. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., and Waku K. 2-arachidonoylgylcerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Comm. 215 (1995) 89-97
140. Thors L., Eriksson J., and Fowler C.J. Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake. Br. J. Pharmacol. 152 (2007) 744-750
141. Tsujishita Y., and Hurley J.H. Structure and lipid transport mechanism of a StAR-related domain. Nat. Struct. Mol. Biol. 7 (2000) 408-414
142. Turcotte L.P., Swenberger J.R., Tucker M.Z., and Yee A.J. Training-induced elevation in FABPPM Is associated with increased palmitate use in contracting muscle. J. Appl. Physiol. 87 (1999) 285-293
143. Twitchell W., Brown S., and Mackie K. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol. 78 (1997) 43-50
144. Vellani V., Petrosino S., De Petrocellis L., Valenti M., Prandini M., Magherini P.C., McNaughton P.A., and Di Marzo V. Functional lipidomics. Calcium-independent activation of endocannabinoid/endovanilloid lipid signalling in sensory neurons by protein kinases C and A and thrombin. Neuropharmacology 55 (2008) 1274-1279
145. Vogel S.M., Minshall R.D., Pilipovic M., Tiruppathi C., and Malik A.B. Albumin uptake and transcytosis in endothelial cells in vivo induced by albumin-binding protein. Am. J. Physiol. Lung Cell. Mol. Physiol. 281 (2001) L1512-L1522
146. Wang H., Dey S.K., and Maccarrone M. Jekyll and Hyde: Two faces of cannabinoid signaling in male and female fertility. Endocrinol. Rev. 27 (2006) 427-448
147. Watkins P.A. Fatty acid activation. Prog. Lipid Res. 36 (1997) 55-83
148. Wei B.Q., Mikkelsen T.S., McKinney M.K., Lander E.S., and Cravatt B.F. A second fatty acid amide hydrolase with variable distribution among placental mammals. J. Biol. Chem. 281 (2006) 36569-36578
149. Wirtz K.W.A. Phospholipid transfer proteins in perspective. FEBS Lett. 580 (2006) 5436-5441
150. Witkin J.M., Tzavara E.T., and Nomikos G.G. A role for cannabinoid CB1 receptors in mood and anxiety disorders. Behav. Pharmacol. 16 (2005) 315-331
151. Yang Y., Chen M., Loux T., and Harmon C. Regulation of FAT/CD36 mRNA gene expression by long chain fatty acids in the differentiated 3T3-L1 cells. Pediatr. Surg. Int. 23 (2007) 675-683
152. Zhou S.L., Stump D., Sorrentino D., Potter B.J., and Berk P.D. Adipocyte differentiation of 3T3-L1 cells involves augmented expression of a 43-kDa plasma membrane fatty acid-binding protein. J. Biol. Chem. 267 (1992) 14456-14461
153. Zhou S.L., Stump D.D., Kinag C.L., Isola L.M., and Berk P.D. Mitochondrial aspartate aminotransferase expressed on the surface of 3T3-L1 adipocytes mediates saturable fatty acid uptake. Proc. Soc. Exp. Biol. Med. 208 (1995) 263-270
154. Zimmerman A.W., and Veerkamp J.H. New insights into the structure and function of fatty acid-binding proteins. Cell. Mol. Life Sci. 59 (2002) 1096-1116
155. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H.H., Sorgard M., Di Marzo V., Julius D., and Hogestatt E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400 (1999) 452-457